|
 |
Brett
Rowland
Counsel
London
+44.20.7360.2064
+44.20.7626.7937 Fax
|
Vcard
|
BRETT ROWLAND is counsel in the London office practising in Healthcare, Intellectual Property and Information Technology law. He has twelve years experience in England and a further ten years in Australia and is admitted to practice as a solicitor in England and Wales and as a barrister and solicitor in Australia.
Among other things, Mr. Rowland has drafted and advised on:
-
healthcare regulatory, advisory, licensing and transactional work
-
intellectual property and information technology acquisitions and disposals
-
technology and rights transfer agreements and joint ventures
-
software and systems agreements, and information technology and business process outsourcing and content carriage and distribution agreements and e-commerce agreements
-
trade and technology law including export control and licensing obligations.
Mr. Rowland has also acted in patent and trade mark litigation in the English High Court and Court of Appeal and the Australian Federal and Supreme Courts including:
-
Merck & Co, Inc. ats Monsanto & Ors – English High Court patent infringement action, Court of Appeal decision reported at [2000] RPC 77
-
Napp Pharmaceutical v Asta Medica & Ors – English High Court patent infringement action, including interlocutory hearing reported at [1999] FSR 370
-
The Body Shop International ats Sockel GmbH & Anor – English High Court trade mark infringement and anti-trust action First Instance and Court of Appeal, first instance decision reported at [2000] UKCLR 262.
He has also acted as supervising solicitor at the execution of Search and Seizure Orders.
He regularly lectures in Intellectual Property and Healthcare Law and has presented at conferences for SMI, the Victoria University of Technology, the University of Melbourne, the Federation Against Software Theft and the International Association of Contract Managers.